AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Montecitojournal

Published November 10, 2026

Psych in! Doublewide Kings and Symphony Re-team for Another Dose - Montecito Journal

Read the full story at Montecitojournal

Call it Psychedelic Symphony, the Sequel, or Son of Psychedelic Symphony, or A Second Season of Psychedelic Symphony. Whatever the alliterative.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics